Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sirolimus Subconjunctival Injection for Dry Eye (CAE Model)
NCT00814944Phase 2Completed
- Sponsor
- Santen Pharmaceutical
- Start
- Apr 2009
- Primary completion
- Oct 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sirolimus in dry eye syndrome (DED), sponsored by Santen Pharmaceutical. Started Apr 2009; status: completed.
02
Drugs
sirolimus
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on NCT00814944.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00814944.